Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,421,880
+$10,420,177 QoQ
Shares Held
66,500
+415525.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#171
of 1,603 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dixon Mitchell Investment Counsel Inc. holds $10,901,778 across 3 Drug Manufacturers - General names. NVS ranks #1 (95.6% of the industry book) .
All Filings in NVS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,421,880 | 66,500 | Shares | Sole | 2026-08-13 | |
| 2024-06-30 | $1,703 | 16 | Shares | Sole | 2024-07-12 | |
| 2021-06-30 | $9,416,606 | 103,207 | Shares | Sole | 2024-01-17 | |
| 2021-03-31 | $8,831,280 | 103,314 | Shares | Sole | 2024-01-17 | |
| 2020-12-31 | $8,595,585 | 91,026 | Shares | Sole | 2024-01-17 | |
| 2020-09-30 | $7,927,099 | 91,158 | Shares | Sole | 2024-01-17 | |
| 2020-06-30 | $4,363,331 | 49,958 | Shares | Sole | 2024-01-17 | |
| 2020-03-31 | $3,912,087 | 47,448 | Shares | Sole | 2024-01-17 | |
| No filing history on record for this holder in this stock. | ||||||